Disrupted sleep affects hormones, appetite regulation, mood, immune function, and paradoxically, weight loss itself
Patients with type 2 diabetes and elevated BMI are among the most clinically well-supported candidates for GLP-1 treatment
Commonly used reducing agents include TCEP, DTT, and bME
So at 2 mg/mL, 50 units is not a lot
This new analysis presented at ECO, focused on the difference in early cardiovascular events with semaglutide versus placebo from randomisation up to 12 months, with a focus on 3 and 6 months, to better understand the drugs effects, time to cardiovascular benefit, as well as predictors that might help identify patients at risk for early cardiovascular events